MedTrace Logo

Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old

NCT00378118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2007-11-06

No results posted yet for this study

Summary

Blood is the most commonly used specimen to test for HIV. In the past 20 years, use of saliva as an alternative specimen for HIV testing has been explored. Today, very sensitive tests have been formulated and have been used for diagnosing HIV in adults and older children. OraQuick, a rapid test, is one such example. It is a devise that can be used to collect as well test the saliva.

Most studies done on the use of saliva have been carried out in adults and have produced very good results. However very few such studies have been done in children, especially infants. In adults, use of saliva has also highlighted the advantages of ease of collection and increased acceptability of testing.

HYPOTHESIS OraQuick rapid test can detect antiHIV antibodies as well as the Abbott determine test and oral fluid testing is more acceptable than blood testing.

Conditions

  • HIV Antibody Testing

Interventions

OTHER

Abbott-rapid HIV antibody test

Abbott will be used to test serum or whole blood

OTHER

OraQuick Rapid HIV-1/2 Antibody test

OraQuick for oral fluid HIV antibody testing

Sponsors & Collaborators

Principal Investigators

  • Catherine M Chunda, Medicine · University of Zambia/University Teaching Hospital

Eligibility

Min Age
1 Day
Max Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2007-09-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378118 on ClinicalTrials.gov